Ottawa, Canada

Daniel McManus


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel McManus

Introduction

Daniel McManus is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of medical research, particularly in cancer treatment. With a total of four patents to his name, McManus has developed innovative methods and compositions that aim to enhance patient outcomes in the fight against proliferative diseases.

Latest Patents

Among his latest patents is a method for treating cancer using IAP antisense oligomer and chemotherapeutic agents. This invention features methods, compositions, and kits designed for treating patients with proliferative diseases. Another significant patent is focused on antisense IAP nucleobase oligomers, which hybridize to IAP polynucleotide. This invention includes methods for using these oligomers to enhance apoptosis and treat various proliferative disorders.

Career Highlights

Throughout his career, McManus has worked with reputable companies such as Aegera Therapeutics, Inc. and Pharmascience Inc. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Daniel McManus has collaborated with several professionals in his field, including Eric LaCasse and Jon P Durkin. These collaborations have further enriched his research and innovation efforts.

Conclusion

In summary, Daniel McManus is a distinguished inventor whose work has significantly impacted cancer treatment methodologies. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…